1-5 of 5
William F Westlin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MYD88 L265P Mutations Influence Clinical Outcome and Identify a Pathway for Targeted Inhibition in Chronic Lymphocytic Leukemia

Bethany Tesar, MS, Reina Improgo, PhD, Josephine L. Klitgaard, MSc,PhD, Reuma Magori-Cohen, Lijian Yu, Divya Chaudhary, Wenyan Miao, Stacey M. Fernandes, Kevin Hoang, William F Westlin, Haesook T. Kim, PhD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2015) 126 (23): 491.
https://doi.org/10.1182/blood.V126.23.491.491
Published: 2015
Journal Articles

Effect Of MYD88 Mutation In CLL On IRAK4 and BTK Inhibition In Vitro

Bethany Tesar, Divya Chaudhary, Lillian Werner, Reina Improgo, Nathalie Pochet, Stacey M Fernandes, Kevin Hoang, Alexander R. Vartanov, Donna L. Romero, Shaughnessy D. Robinson, Donna S. Neuberg, ScD, William F. Westlin, Jennifer R. Brown, M.D.
Journal: Blood
Blood (2013) 122 (21): 4132.
https://doi.org/10.1182/blood.V122.21.4132.4132
Published: 2013
Journal Articles

Synergistic Blockade Of Activated B Cell-Like DLBCL Proliferation With a Selective Inhibitor Of IRAK4 In Combination With Inhibition Of The B-Cell Receptor Signaling Network

Divya Chaudhary, Nancy Wood, Donna L. Romero, Shaughnessy D. Robinson, Jeremy R Greenwood, Mee Shelley, Michael Morin, Rosana Kapeller, William F Westlin
Journal: Blood
Blood (2013) 122 (21): 3833.
https://doi.org/10.1182/blood.V122.21.3833.3833
Published: 2013
Journal Articles

A Novel Bruton′s Tyrosine Kinase Inhibitor CC-292 In Combination With The Proteasome Inhibitor Carfilzomib Iimpacts Multiple Myeloma Bone Microenviroment With Resultant Anti-Myeloma Activity

Homare Eda, Loredana Santo, Diana D Cirstea, Andrew J Yee, Tyler A Scullen, Neeharika Nemani, Yuko Mishima, Shirin Arastu-Kapur, Erica Evans, Juswinder Singh, Christopher J Kirk, William F Westlin, Noopur S Raje
Journal: Blood
Blood (2013) 122 (21): 682.
https://doi.org/10.1182/blood.V122.21.682.682
Published: 2013
Journal Articles

Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies,

Erica Evans, PhD, Richland Tester, PhD, Sharon Aslanian, Prasoon Chaturvedi, PhD, Hormoz Mazdiyasni, Sabine Ponader, PhD, Bethany Tesar, Michael Sheets, Mariana Nacht, PhD, Kathryn Stiede, Steve Witowski, PhD, Heather Lounsbury, Russell Petter, PhD, Jennifer R. Brown, MD, PhD, Jan A. Burger, MD, PhD, Juswinder Singh, PhD, William F. Westlin, PhD
Journal: Blood
Blood (2011) 118 (21): 3485.
https://doi.org/10.1182/blood.V118.21.3485.3485
Published: 2011